专科
91 个治疗项目
全部治疗
可选治疗路径
91 个治疗项目
OncologyCAR-T
Chimeric antigen receptor T-cell therapy (CAR-T) may be considered in non-Hodgkin lymphoma that is relapsed or refractory and remains active after multiple lines of prior therapy, commonly in B-cell lymphomas expressing the corresponding target. The decision is influenced by factors such as patholog
OncologyCAR-T 细胞治疗
CAR-T cell therapy may be considered in children with relapsed/refractory B-cell acute lymphoblastic leukemia or persistent MRD positivity, with CD19/CD22 as common targets. The decision depends on antigen expression, previous treatment and relapse risk, whether bridging therapy is needed, organ fun
OncologyRPLND（开放/腹腔镜）
Retroperitoneal Lymph Node Dissection (RPLND) may be considered in non-seminomatous germ cell tumors (NSGCT) with residual or stable retroperitoneal lymph nodes after systemic therapy, or as an early selective staging/treatment option. The decision depends on lesion size and location, changes in tum
OncologyTORS
Transoral robotic resection can be considered when benign pharyngeal tumors or early to partially localized malignant tumors can be adequately exposed transorally based on imaging and endoscopy. The decision is influenced by the location and size of the lesion, extralaryngeal invasion, history of pr
Oncology乳房切除术
Mastectomy can be considered when there is multicentric or extensive disease, relatively large tumor volume, contraindications to radiation therapy, or recurrence after breast-conserving surgery. Whether to preserve the nipple-areola complex and the method of axillary management depend on imaging an
Oncology低剂量率近距离治疗（I-125）
It is often used for radical treatment of low-risk or some favorable intermediate-risk prostate cancer, and can be combined with external beam radiation therapy in some high-risk patients; it can also be used for salvage treatment after recurrence under strict selection. The decision considers risk